论文部分内容阅读
目的评价依达拉奉治疗发病6~12h进展性脑梗死的疗效。方法治疗组25例用依达拉奉30mg静脉滴注,每天2次,7d为一疗程,对照组25例用生理盐水静脉滴注作对照。结果治疗组显效率(72%)高于对照组(32%),P=0.01,差异有显著性意义;总有效率两组无差异,未发现明显副作用。结论依达拉奉治疗进展性脑梗死是安全有效的。
Objective To evaluate the efficacy of edaravone in the treatment of progressive cerebral infarction from 6 to 12 hours. Methods 25 cases of treatment group with Edaravone 30mg intravenous infusion, 2 times a day, 7d for a course of treatment, 25 cases of control group with saline intravenous injection as a control. Results The effective rate (72%) in the treatment group was significantly higher than that in the control group (32%), P = 0.01, the difference was statistically significant. The total effective rate was no difference between the two groups and no obvious side effects were found. Conclusion Edaravone is safe and effective in treating progressive cerebral infarction.